Abstract: The invention relates to a method of 13C-MR detection using an imaging medium comprising hyperpolarised 13C-lactate and to an imaging medium containing hyperpolarised 13C1-lactate for use in said method.
Type:
Application
Filed:
July 25, 2008
Publication date:
August 5, 2010
Inventors:
Matilde H. Lerche, Anna Gisselsson, Georg Hansson, Sven Mansson, Rene in't Zandt, Magnus Karlsson, Pernille R. Jensen
Abstract: One aspect of the present invention relates to a method for the kinetic resolution of racemic and diastereomeric mixtures of chiral compounds. The critical elements of the method are: a non-racemic chiral tertiary-amine-containing catalyst; a racemic or diastereomeric mixture of a chiral substrate, e.g., a cyclic carbonate or cyclic carbamate; and a nucleophile, e.g., an alcohol, amine or thiol. A preferred embodiment of the present invention relates to a method for achieving the kinetic resolution of racemic and diastereomeric mixtures of derivatives of ?- and ?-amino, hydroxy, and thio carboxylic acids. In certain embodiments, the methods of the present invention achieve dynamic kinetic resolution of a racemic or diastereomeric mixture of a substrate, i.e.
Abstract: A process for producing an optically active 2-hydroxybutyric ester represented by formula (1): by reacting an optically active 2,3-epoxypropionic ester represented by formula (2): with a methyl Grignard reagent CH3MgX in the presence of a copper catalyst in an amount of 0.05 to 0.5 mol with respect to 1 mol of the 2,3-epoxypropionic ester.
Abstract: The present invention provides a method of producing a fluoropolymer, wherein polymerization using a carboxylate ester bond-containing carboxylic acid derivative as a surfactant in an aqueous medium to give the fluoropolymer is conducted, the above carboxylate ester bond-containing carboxylic acid derivative has a carboxylate ester bond and —COOM (M representing H, NH4, Li, Na or K), the above carboxylate ester bond may optionally be substituted by fluorine atom.
Abstract: Integrated processes of preparing industrial chemicals starting from seed oil feedstock compositions containing one or more unsaturated fatty acids or unsaturated fatty acid esters, which are essentially free of metathesis catalyst poisons, particularly hydroperoxides; metathesis of the feedstock composition with a lower olefin, such as ethylene, to form a reduced chain olefin, preferably, a reduced chain ?-olefin, and a reduced chain unsaturated acid or ester, preferably, a reduced chain ?,?-unsaturated acid or ester. The reduced chain unsaturated acid or ester may be (trans)esterified to form a polyester polyolefin, which may be epoxidized to form a polyester polyepoxide. The reduced chain unsaturated acid or ester may be hydroformylated with reduction to produce an ?,?-hydroxy acid or ?,?-hydroxy ester, which may be (trans)esterified with a polyol to form an ?,?-polyester polyol.
Type:
Grant
Filed:
December 5, 2008
Date of Patent:
June 29, 2010
Assignee:
Dow Global Technologies Inc.
Inventors:
Zenon Lysenko, Bob R. Maughon, Jozef Bicerano, Kenneth A. Burdett, Christopher P. Christenson, Clark H. Cummins, Marvin L. Dettloff, Alan K. Schrock, P. J. Thomas, Richard D. Varjian, Jerry E. White, John Michael Maher
Abstract: The present invention relates to a process for producing organic carboxylic acid esters, in which an amino-ester exchange reaction of an organic carboxylic acid amide with an ester compound, or with an alcohol compound under a CO pressure, is carried out at a specific temperature in the presence of a catalyst and a promoter, so as to produce an organic carboxylic acid ester.
Type:
Application
Filed:
February 17, 2009
Publication date:
June 24, 2010
Applicant:
CHINA PETROCHEMICAL DEVELOPMENT CORPORATION
Inventors:
Yu Chiao Liu, Chin Yi Lee, Chia Jung Tsai
Abstract: A method whereby a compound having HCV replication inhibitory activity and desired optical activity can be synthesized selectively and at high yield in a small number of steps by using a compound having a specific chiral auxiliary as a starting compound is provided. A compound represented by the formula (1-8): wherein Y represents a group represented by the following formula: Q represents a protected carbonyl group; D represents —(CH2)m—R?, etc.; and n represents an integer of 0 to 10.
Abstract: The subject matter of the invention is a process for the production of metal salts of trifluoromethane sulphonic acid by reacting trifluoromethane sulphonic acid with a metal alcoholate and the use thereof as esterification catalyst and/or transesterification catalyst for the production of hydroxycarboxylic acid esters.
Type:
Grant
Filed:
November 18, 2004
Date of Patent:
June 1, 2010
Assignee:
Sasol Solvents Germany GmbH
Inventors:
Peter Finmans, Detlef Hoell, Hans-Jurgen Vossler, Martina Rozek, Michael James Green, Rafael Roggenbuck
Abstract: A particulate polyglycolic acid resin composition suitable as a material for various forming processes in produced through a process characterized by comprising: cooling a polyglycolic acid resin composition having a residual glycolide content of at most 0.6 wt. % in a molten state by contact with an aqueous cooling medium to solidify the composition, and pelletizing the composition.
Abstract: The invention relates to new diols and polyols which are hydroxypropyl esters of hydroxycarboxylic or polycarboxylic acids. The new diols and polyols are useful as monomer compounds and reactive solvents.
Type:
Application
Filed:
March 26, 2008
Publication date:
May 27, 2010
Applicant:
COGNIS IP MANAGEMENT GMBH
Inventors:
Joaquin Bigorra Llosas, Luis Llaurdo, Francesc Gusi
Abstract: A process for the production of lactic acid and 2-hydroxy-3-butenoic acid or esters thereof by conversion of glucose, fructose, sucrose, xylose and glycolaldehyde dissolved in a solvent in presence of a solid Lewis acidic catalyst.
Type:
Application
Filed:
November 6, 2009
Publication date:
May 13, 2010
Inventors:
Esben Taarning, Saravanamurugan Shunmugavel, Martin Spangsberg Holm
Abstract: A medicament having inhibitory activity against NF-?B activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in a main chain is 2 to 5 (said connecting group may be substituted), “A” represents an acyl group which may be substituted, (provided that unsubstituted acetyl group and unsubstituted acryloyl group are excluded,) or a C1 to C6 alkyl group which may be substituted, or A may bind to connecting group X to form a cyclic structure which may be substituted, “E” represents an aryl group which may be substituted or a heteroaryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group r
Type:
Application
Filed:
October 14, 2009
Publication date:
May 6, 2010
Applicant:
INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC.
Abstract: Catalyst systems consisting of supported or unsupported transition metal catalysts which have modifiers on the surface. The modifiers have sulphur-containing functionalities (G0). In addition, the modifiers may have a spacer (Sp) and a Bronsted-basic, Bronsted-acidic or Lewis-basic functionality (G1). The catalyst systems may be used for hydrogenation, reductive alkylation and reductive amination.
Type:
Application
Filed:
January 28, 2008
Publication date:
April 29, 2010
Inventors:
Dorit Wolf, Thomas Riermeier, Karlheinz Drauz, Christoph Weber
Abstract: This invention provides a method for producing a lactic acid ester that can minimize input energy at the time of production, that can reduce chemical costs, and that can minimize equipment costs. This method comprises steps of: performing an esterification reaction in a reaction solution containing ammonium lactate obtained via fermentation and alcohol with an ammonia concentration of 1.0% by weight or lower; and recovering the lactic acid ester synthesized in the above step.
Abstract: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.
Type:
Application
Filed:
August 14, 2009
Publication date:
March 25, 2010
Inventors:
Kenneth Edward Yelm, Gregory Mark Bunke, John Christian Haught
Abstract: An engineered nano-composite coating may include hydrophobic an hydrophilic domains, may be applied to transparent and non-transparent substrates using a continuous process, may be UV curable and may impart antifogging characteristics to the substrate.
Type:
Application
Filed:
February 8, 2007
Publication date:
February 4, 2010
Applicant:
Industrial Science & Technology Network Inc. Cyber Center
Abstract: A method for stabilizing menthyl lactate is disclosed. The method comprises combining water with a solution comprising menthyl lactate and a water-miscible organic solvent in amounts effective to precipitate menthyl lactate from the resulting aqueous mixture. The aqueous precipitation method is simple to practice, and it provides menthyl lactate having remarkably improved storage stability.
Abstract: A process for producing organic acid esters using continuous countercurrent reactive distillation using acid catalysts in a structured packing in a single column (10) is described. In the reactive distillation an organic acid ester is formed by chemical reaction and can be purified to its final state within the single column. Organic acid esters are produced at relatively low cost, with less waste production, and in a less complicated manner than prior processes. Organic acid ester have uses as solvents, as intermediate chemicals, and in consumer products.
Type:
Grant
Filed:
July 19, 2004
Date of Patent:
January 26, 2010
Assignee:
Board of Trustees of Michigan State University
Inventors:
Dennis J. Miller, Navinchandra Asthana, Aspi Kolah, Carl T. Lira
Abstract: Provided herein are catalysts useful in enabling and promoting the insertion of alkylene oxides into ester linkages. The esters employed as a substrate to be alkoxylated include esters of fatty acids, such as methyl esters of C14 to C22 fatty acids, and mono-, di-, and tri-esters of glycerine, including vegetable oils, animal fats, and plant oils. A catalyst according to the invention includes at least two alkaline earth compounds, which may include any known stable compounds of the alkaline earths, and optionally contains one or more additional materials such as a carboxylic acid or a polyalkylene glycol having a molecular weight between about 100 and 1500 or a C1-C10 alkyl-capped polyalkylene glycol having molecular weight between about 100 and 1500, which has been acidified with a strong mineral acid. The preferred alkaline earths employed are salts and compounds of magnesium and calcium.
Type:
Grant
Filed:
May 31, 2005
Date of Patent:
December 8, 2009
Assignee:
Huntsman Petrochemical LLC
Inventors:
George A. Smith, James O'Neill, Lindy R. Coker, legal representative, George Sneed, Christopher J. Whewell
Abstract: Preparation of derivatives of ?-hydroxycarboxylic acid, including ?-hydroxycarboxylic acid esters, ?,?-unsaturated carboxylic acid, esters of ?,?-unsaturated carboxylic acid, and alkoxy derivatives.
Type:
Application
Filed:
July 21, 2009
Publication date:
December 3, 2009
Inventors:
Paraskevas Tsobanakis, Xiangsheng Meng, Timothy W. Abraham
Abstract: Compounds of the formula I or I?, where the radicals R1 are each, independently of one another, a hydrogen atom or C1-C4-alkyl and R?1, is C1-C4-alkyl; X1 and X2 are each, independently of one another, a sec-phosphino group; R2 is hydrogen, R01R02R03Si— is halogen-, hydroxyl-, C1-C8-alkoxy- or R04R05N-substituted C1-C18-acyl or is R06—X01—C(O)—; R01, R02 and R03 are each, independently of one another, C1-C12-alkyl, unsubstituted or C1-C4-alkyl- or C1-C4-alkoxy-substituted C6-C10-aryl or C7-C12-aralkyl; R04 and R05 are each, independently of one another, hydrogen, C1-C12-alkyl, C3-C8-cycloalkyl, C6-C10-aryl or C7-C12-aralkyl, or R04 and R05 together are trimethylene, tetramethylene, pentamethylene or 3-oxapentylene; R06 is C1-C18-alkyl, unsubstituted or C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl, C6-C10-aryl or C7-C12-aralkyl; X01 is —O— or —NH—; T is C-bonded C3-C20-heteroarylene; v is 0 or an integer from 1 to 4; X1 in the heteroring of the heteroarylene is bound in the ortho position relative
Type:
Application
Filed:
April 19, 2006
Publication date:
October 29, 2009
Inventors:
Martin Kesselgruber, Marc Thommen, Mathias Lotz
Abstract: A method of using organic compounds and providing slow release flavoring in or for food products wherein flavor precursors are added to flavor compositions and/or food products and release flavor compounds upon consumption of the food products, and novel flavor precursor compounds. The flavor precursors can be prepared from mono- and/or diglycerides and lactone flavor compounds.
Abstract: The present invention relates to a method of protecting a hydroxyl group, which includes reacting a hydroxyl group-containing compound with a compound represented by the formula (I): wherein R is a phenyl group optionally having substituent(s), an alkyl group optionally having substituent(s) or a benzyl group optionally having substituent(s), and X is a halogen atom, in the presence of an acid catalyst to substitute the hydrogen atom of the hydroxyl group of the hydroxyl group-containing compound with a protecting group represented by the formula (II): wherein R is as defined above. The present invention provides a method capable of introducing an acetal type protecting group into a hydroxyl group under mild conditions, and a protecting reagent therefor and a method of producing the protecting reagent.
Abstract: The invention is directed to methods of making organic compounds by metathesis and hydrocyanation. The method of the invention may be used, for example, to make industrial important organic compounds such as diacids, diesters, acid-amines, acid-alcohols, acid-nitriles, ester-amines, ester-alcohols, and ester-nitriles.
Type:
Application
Filed:
April 10, 2009
Publication date:
October 15, 2009
Inventors:
Timothy W. Abraham, Hiroki Kaido, Choon Woo Lee, Richard L. Pederson, Yann Schrodi, Michael John Tupy, Alexandre A. Pletnev
Abstract: A process for producing an optically active 2-hydroxybutyric ester (1), characterized by including reacting an optically active 2,3-epoxybutyric ester (2) with a thiol in the presence of scandium trifluoromethanesulfonate or ytterbium trifluoromethanesulfonate, to thereby produce Compound (3), and subjecting Compound (3) to desulfurization reaction: (wherein R represents a C1 to C6 alkyl group or a C7 or C8 aralkyl group; R1 represents a C1 to C12 alkyl group or a phenyl group; and * represents S- or R-absolute configuration). The present invention provides a process for producing an optically active 2-hydroxybutyric ester at high yield and high optical purity.
Abstract: Continuous process for preparing alpha-hydroxycarboxylic esters, in which the reactants reacted are alpha-hydroxycarboxamide with an alcohol in the presence of a catalyst to obtain a product mixture which comprises alpha-hydroxycarboxylic ester, ammonia, unconverted alpha-hydroxycarboxamide and alcohol, and catalyst; wherein a?) reactant streams comprising, as reactants, an alpha-hydroxycarboxamide, an alcohol and a catalyst are fed into a pressure reactor; b?) the reactant streams are reacted with one another in the pressure reactor at a pressure in the range of 1 bar to 100 bar; c?) the product mixture which results from step b) and comprises alpha-hydroxycarboxylic ester, unconverted alpha-hydroxycarboxamide and catalyst, and also ammonia and alcohol, is discharged from the pressure reactor; and d?) the product mixture is depleted in alcohol and ammonia by distilling off ammonia at a pressure which is constantly kept greater than 1 bar without the aid of additional stripping media.
Type:
Application
Filed:
May 25, 2007
Publication date:
August 20, 2009
Applicant:
Evonik Roehm GmbH
Inventors:
Jochen Ackermann, Alexander May, Udo Gropp, Hermann Siegert, Bernd Vogel, Sönke Bröcker
Abstract: To provide a process for producing an optically active 2-hydroxybutyric ester at high yield and high optical purity. The process for producing an optically active 2-hydroxybutyric ester (1), characterized in that the process includes reacting an optically active 2,3-epoxypropionic ester (2) with a methyl Grignard reagent CH3MgX (wherein X represents a halogen atom) in the presence of a copper catalyst in an amount of 0.05 to 0.5 mol with respect to 1 mol of (2) through the following scheme: (wherein R represents a C1 to C6 alkyl group or a C7 or C8 aralkyl group; X represents a halogen atom; and * represents S- or R-absolute configuration).
Abstract: The present invention provides a method of producing a fluoropolymer, wherein polymerization using a carboxylate ester bond-containing carboxylic acid derivative as a surfactant in an aqueous medium to give the fluoropolymer is conducted, the above carboxylate ester bond-containing carboxylic acid derivative has a carboxylate ester bond and —COOM (M representing H, NH4, Li, Na or K), the above carboxylate ester bond may optionally be substituted by fluorine atom.
Abstract: The present invention relates to a process for the continuous preparation of selected organic peroxides using plate exchangers having a high heat exchange capacity.
Type:
Application
Filed:
April 27, 2007
Publication date:
July 16, 2009
Applicant:
Arkema France
Inventors:
Jean-Marc Corpart, Sandra Grimaldi, Georges Martino-Gauchi, Philippe Maj
Abstract: Continuous process for preparing alpha-hydroxycarboxylic esters, in which the reactants reacted are alpha-hydroxycarboxamide with an alcohol in the presence of a catalyst to obtain a product mixture which comprises alpha-hydroxycarboxylic ester, ammonia, unconverted alpha-hydroxycarboxamide and alcohol, and catalyst; wherein reactant streams comprising, as reactants, an alpha-hydroxycarboxamide, an alcohol and a catalyst are fed into a pressure reactor; the reactant streams are reacted with one another in the pressure reactor at a pressure in the range of 1 bar to 100 bar; and the product mixture is depleted in alcohol and ammonia by distilling off ammonia at a pressure which is constantly kept greater than 1 bar without the aid of additional stripping media. The continuous process can be employed particularly advantageously on the industrial scale.
Type:
Application
Filed:
March 28, 2007
Publication date:
July 16, 2009
Applicant:
Evonik Roehm GmbH
Inventors:
Alexander May, Bernd Vogel, Hermann Siegert, Jochen Ackermann, Sönke Bröcker
Abstract: The present invention relates to chain extenders, processes for their preparation and their use in the preparation of biocompatible biodegradable polyurethanes and polyurethane ureas for biomedical applications such as stents, scaffolds for tissue engineering.
Abstract: A process for the carbonylation of ethylenically unsaturated compounds including vinyl esters and a process for the production of 3-hydroxy propanoate esters or acids. The process comprises reacting said compound with carbon monoxide in the presence of a source of hydroxyl groups and of a catalyst system. The catalyst system is obtainable by combining: (a) a metal of Group 8, 9 or 10 or a compound thereof: and (b) a bidentate ligand of general formula (I): X1(X2)-Q2-A-R—B-Q1-X3(X4).
Type:
Application
Filed:
November 8, 2006
Publication date:
June 25, 2009
Applicant:
Lucite International Uk Limited
Inventors:
Graham Ronald Eastham, Mark Waugh, Philip Ian Richards
Abstract: Derivative compounds of 11-nonyloxy-undec-8(Z)-eonic acid that mimic epoxide metabolites are provided. Also provided are compositions comprising a therapeutically effective amount of the derivative compounds. The present invention further provides methods for the use of such compositions for the treatment of renal or cardiovascular disease and/or related conditions.
Type:
Grant
Filed:
October 2, 2007
Date of Patent:
June 23, 2009
Assignees:
Medical College of Georgia Research Institute, Board of Regents, The University of Texas System
Abstract: Integrated processes of preparing industrial chemicals starting from seed oil feedstock compositions containing one or more unsaturated fatty acids or unsaturated fatty acid esters, which are essentially free of metathesis catalyst poisons, particularly hydroperoxides; metathesis of the feedstock composition with a lower olefin, such as ethylene, to form a reduced chain olefin, preferably, a reduced chain ?-olefin, and a reduced chain unsaturated acid or ester, preferably, a reduced chain ?,?-unsaturated acid or ester. The reduced chain unsaturated acid or ester may be (trans)esterified to form a polyester polyolefin, which may be epoxidized to form a polyester polyepoxide. The reduced chain unsaturated acid or ester may be hydroformylated with reduction to produce an ?,?-hydroxy acid or ?,?-hydroxy ester, which may be (trans)esterified with a polyol to form an ?,?polyester polyol.
Type:
Application
Filed:
December 5, 2008
Publication date:
June 4, 2009
Applicant:
Dow Global Technologies Inc.
Inventors:
Zenon Lysenko, Bob R. Maughon, Jozef Bicerano, Kenneth A. Burdett, Christopher P. Christenson, Clark H. Cummins, Marvin L. Dettloff, Alan K. Schrock, P. J. Thomas, Richard D. Varjian, Jerry E. White, John Michael Maher
Abstract: The invention relates to novel compounds of formula (I): H2N—CH(R1)—CH2—S—S—CH2—CH(R2)—COONH—R5, wherein R1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R2 is a phenyl or benzyl radical, a 5 or 6 atom aromatic heterocycle, methylene group substituted by a 5 or 6 atom heterocycle; R5 is a CH(R3)—COOR4 radical, wherein R3 is hydrogen, an OH or OR group, a saturated hydrocarbon group, a phenyl or benzyl radical and OR4 is hydrophile ester, or 5 or 6 membered heterocycle comprising several heteroatoms selected from a group consisting of nitrogen, sulphur and oxygen, with at least two nitrogene atoms, wherein said heterocycle is substitutable by an alkyl C1-C6, phenyl or benzyl radical.
Type:
Application
Filed:
October 24, 2006
Publication date:
May 21, 2009
Applicant:
PHARMALEADS
Inventors:
Bernard Roques, Marie-Claude Fournie-Zaluski
Abstract: A process for producing a 6-hydroxycarpoic ester and a process for producing a trialkylamine in both of which nylon-6, ?-caprolactam, which is a monomer therefor, etc. are used as a raw material. The processes are intended to make nylon-6 wastes reusable in various applications without consuming a large quantity of energy. The process for producing a 6-hydroxycarpoic ester and process for producing a trialkylamine are characterized by reacting amide compounds basically comprising ?-caprolactam with an alcohol in a supercritical state to obtain a 6-hydroxycarpoic ester and a trialkylamine.
Abstract: The present invention relates to a continuous process for the cyanation of hydrogenated ?-ketoesters in a cyanation zone maintained under conditions of temperature and pressure effective for cyanation of a hydrogenated R-ketoester. A substrate comprising a hydrogenated ?-ketoester is continuously supplyed to the cyanation zone together with a cyanide. The substrate is contacted with the cyanide in the cyanation zone for a period effective for at least partial cyanation of the hydrogenated ?-ketoester and a product stream is continuously extracted from the cyanation zone.
Abstract: A process for producing an optically active 2-hydroxybutyric ester (1), characterized by including reacting an optically active 2,3-epoxybutyric ester (2) with a thiol in the presence of scandium trifluoromethanesulfonate or ytterbium trifluoromethanesulfonate, to thereby produce Compound (3), and subjecting Compound (3) to desulfurization reaction: (wherein R represents a C1 to C6 alkyl group or a C7 or C8 aralkyl group; R1 represents a C1 to C12 alkyl group or a phenyl group; and * represents S- or R-absolute configuration). The present invention provides a process for producing an optically active 2-hydroxybutyric ester at high yield and high optical purity.
Abstract: The present invention relates to a method for obtaining a carboxylic acid ester from an aqueous solution of the corresponding carboxylic acid ammonium salt using alcoholysis. The recovered carboxylic acid ester may be subsequently hydrolyzed to produce the corresponding carboxylic acid.
Abstract: The invention relates to novel synthesis methods for the preparation of statin derivatives, which methods proceed by way of a key intermediate of formula I wherein X is halogen, acyloxy, activated hydrocarbyloxy, activated hydrocarbylthio or —N(CH3)OCH3, Ra is a hydroxy-protecting group and Rb is a carboxy-protecting group, and, as well as to the compound of formula I, to further new intermediates and methods for their preparation by Friedel-Crafts acylation.
Type:
Application
Filed:
July 24, 2008
Publication date:
December 18, 2008
Inventors:
Reinhold Ohrlein, Gabriele Baisch, Nicole End, Stephan Burkhardt, Martin Studer
Abstract: The present invention relates to a method of producing polyhydroxyalkanoates (PHAs) using Bacillus sp. with succinate as a carbon source. The PHAs comprise more than 95% of poly(3-hydroxyvalerate-co-4-hydroxyvalerate) (P3HV-co-P4HV).
Abstract: Ester compounds of the formula I-a wherein R1 is selected from OH, NH2 and NH3+X?, wherein X is an inorganic anion, wherein R2 is a singly-branched saturated or unsaturated aliphatic hydrocarbon moiety selected from C7-C15, wherein R5 is selected from H, and a linear saturated or unsaturated aliphatic hydrocarbon moiety selected from C6-C14, and wherein R2 and R5 together have a total of 7 to 15 carbon atoms; that are useful as antibacterial or antifungal compounds in consumer products.
Type:
Grant
Filed:
August 31, 2005
Date of Patent:
December 2, 2008
Assignee:
Givaudan S.A.
Inventors:
Samuel Derrer, Andreas Natsch, Bernd Traupe, Melanie Stang
Abstract: A method for stabilizing menthyl lactate is disclosed. The method comprises combining water with a solution comprising menthyl lactate and a water-miscible organic solvent in amounts effective to precipitate menthyl lactate from the resulting aqueous mixture. The aqueous precipitation method is simple to practice, and it provides menthyl lactate having remarkably improved storage stability.
Abstract: The present invention relates to an isoxazoline derivative having the cyclic carboxylic acid hemiketal moiety of formula (1) for use as caspase inhibitor, a process for preparing it, and a pharmaceutical composition comprising it.
Type:
Application
Filed:
February 21, 2006
Publication date:
October 23, 2008
Inventors:
Hyun Ik Shin, Hyeong Wook Choi, Tae Ho Heo, Kyu Woong Lee, Jae Hoon Lee, Ki Sook Park
Abstract: Alkoxy[13C]methyl phenyl sulfone is a precursor to the production of Lithium (E)-?-Alkoxy[1,2,3-13C3]acrylate and thence Alkoxy (E)-?-Alkoxy[1,2,3-13C3]acrylate. Alkoxy (E)-?-Alkoxy[1,2,3-13C3]acrylate can then serve as a precursor for the production of a number of other isotopically labeled compounds. Similar chemistry using Alkoxy[14C]methyl phenyl sulfone as the precursor can yield 14C labeled compounds. High purity precursors ensure that the new compounds are also highly pure.
Abstract: Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability The invention thus provides the use of compounds of the formula (1) where R1, R2 are each independently C1- to C22-alkyl, C2- to C22-alkenyl, C6- to C30-aryl or C7- to C30-alkylaryl, R3 is C1- to C22-alkyl, C2- to C22-alkenyl, C6- to C30-aryl or C7- to C30-alkylaryl, —CHR5—COO? or —O?, R4 is M, hydrogen or an organic radical which optionally contains heteroatoms and has from 1 to 100 carbon atoms, B is an optionally substituted C1- to C10-alkylene group, D is an ethylene group substituted by an organic radical having from 1 to 600 carbon atoms, X, Y are each independently O or NR6, R5, R6 are each independently hydrogen, C1- to C22-alkyl, C2- to C22-alkenyl, C6- to C30-aryl or C7- to C30-alkylaryl, and M is a cation as corrosion and gas hydrate inhibitors, and also the compounds of formula 1.
Abstract: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.